Private Capital Group’s Maravai LifeSciences MRVI Stock Holding History

Private Capital Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Hold	60	–	–	﹤0.01%	1552
2022 Q1	$2K	Hold	60	–	–	﹤0.01%	1799
2021 Q4	$3K	Hold	60	–	–	﹤0.01%	1698
2021 Q3	$3K	Buy	60 +37	+161%	+$1.8K	﹤0.01%	1752
2021 Q2	$1K	Buy	23 +12	+109%	+$465	﹤0.01%	1993
2021 Q1	$0	Buy	11 +6	+120%	+$199	﹤0.01%	2123
2020 Q4	$0	Buy	+5	New	+$139	﹤0.01%	2105

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Private Capital Group's MRVI Position: Q2 2022 in Review

Private Capital Group held its Maravai LifeSciences (MRVI) position steady in Q2 2022 at 60 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

Private Capital Group first reported a position in MRVI in Q4 2020 and has held it in 7 quarters since. The position peaked at $3K in Q4 2021. 216 funds tracked by Wall St. Rank hold MRVI as of Q2 2022.

Private Capital Group held 60 shares of Maravai LifeSciences worth $2K as of Q2 2022.
Private Capital Group left its Maravai LifeSciences share count unchanged in Q2 2022.
Maravai LifeSciences made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1552 holding.
Private Capital Group first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 7 quarters since.
Private Capital Group's Maravai LifeSciences position peaked at $3K in Q4 2021.
216 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.